During a telephone conversation with his Bolivian counterpart Luis Arce, Russian President Vladimir Putin discussed the development of Russian-Bolivian relations and cooperation in the fight against the spread of coronavirus infection in the use of vaccines, the Kremlin press service reported.
“The importance of the agreements reached in December 2020 on the supply of the Russian drug Sputnik V to Bolivia was emphasized and it was agreed to continue close cooperation in this direction,” the statement said.
On January 6, the Russian Direct Investment Fund (RDIF) reported that the Bolivian regulatory agency has registered the Russian Sputnik V coronavirus vaccine for use in the country.
Registration was carried out under an expedited procedure. The vaccine received the approval of the State Agency for Medicines and Technologies in Healthcare without additional clinical trials in Bolivia based on the results of the third phase of clinical trials in Russia.
On December 30, 2020, it was announced that 5.2 million doses of vaccine were delivered to Bolivia to vaccinate 2.6 million people (more than 20% of the country’s population).